A Study Evaluating the Safety, Pharmacokinetics and Anti-Tumor Activity of ABBV-176 in Subjects With Advanced Solid Tumors Likely to Express Prolactin Receptor (PRLR)

Sydney Children's Hospital /ID# 162917, Randwick

Rigshospitalet /ID# 159707, Copenhagen Ø

Mater Misericordiae /ID# 162918, South Brisbane

Hosp Univ Madrid Sanchinarro /ID# 161644, Madrid

Washington University-School of Medicine /ID# 162745, St Louis

City of Hope /ID# 161079, Duarte

HonorHealth Research Institute - Pima /ID# 161078, Scottsdale

Yale University /ID# 201357, New Haven

St. Lukes Cancer Institute /ID# 201353, Kansas City

Rutgers Cancer Institute of NJ /ID# 161080, New Brunswick

University of Utah /ID# 161606, Salt Lake City